Texas Permanent School Fund’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-59,524
Closed -$2.11M 658
2024
Q1
$2.11M Buy
59,524
+870
+1% +$34.8K 0.02% 1034
2023
Q4
$2.55M Sell
58,654
-985
-2% -$38.8K 0.02% 913
2023
Q3
$2.28M Sell
59,639
-3,101
-5% -$130K 0.02% 888
2023
Q2
$2.58M Sell
62,740
-2,422
-4% -$117K 0.02% 845
2023
Q1
$3.74M Buy
65,162
+16,313
+33% +$919K 0.04% 617
2022
Q4
$2.74M Sell
48,849
-3,402
-7% -$173K 0.04% 586
2022
Q3
$2.21M Buy
52,251
+418
+0.8% +$21.4K 0.04% 674
2022
Q2
$2.8M Buy
51,833
+191
+0.4% +$11.5K 0.04% 564
2022
Q1
$3.32M Sell
51,642
-874
-2% -$57.5K 0.05% 554
2021
Q4
$3.52M Sell
52,516
-1,291
-2% -$87.3K 0.04% 557
2021
Q3
$3.69M Buy
53,807
+880
+2% +$62.2K 0.05% 526
2021
Q2
$3.61M Sell
52,927
-20
-0% -$1.41K 0.04% 552
2021
Q1
$3.66M Sell
52,947
-3,893
-7% -$264K 0.05% 525
2020
Q4
$3.69M Sell
56,840
-9,283
-14% -$500K 0.05% 477
2020
Q3
$3.12M Buy
66,123
+10,486
+19% +$499K 0.04% 523
2020
Q2
$2.61M Sell
55,637
-5,026
-8% -$247K 0.04% 531
2020
Q1
$2.71M Buy
60,663
+11,915
+24% +$625K 0.05% 445
2019
Q4
$2.84M Buy
48,748
+427
+0.9% +$25.4K 0.04% 533
2019
Q3
$2.9M Buy
48,321
+172
+0.4% +$10.2K 0.05% 496
2019
Q2
$2.69M Buy
48,149
+118
+0.2% +$6.08K 0.04% 547
2019
Q1
$2.68M Buy
48,031
+1,766
+4% +$89.9K 0.04% 532
2018
Q4
$2.09M Buy
46,265
+1,806
+4% +$99.1K 0.04% 612
2018
Q3
$2.93M Sell
44,459
-1,071
-2% -$66.6K 0.04% 526
2018
Q2
$2.93M Buy
45,530
+3,449
+8% +$214K 0.04% 550
2018
Q1
$2.33M Sell
42,081
-888
-2% -$46.5K 0.03% 676
2017
Q4
$2.06M Sell
42,969
-3,201
-7% -$157K 0.03% 770
2017
Q3
$2.33M Buy
46,170
+2,001
+5% +$103K 0.03% 719
2017
Q2
$2.41M Buy
44,169
+889
+2% +$42.5K 0.03% 689
2017
Q1
$1.82M Sell
43,280
-348
-0.8% -$14.9K 0.02% 811
2016
Q4
$1.87M Sell
43,628
-1,910
-4% -$77.6K 0.02% 814
2016
Q3
$1.88M Buy
45,538
+1,144
+3% +$47.9K 0.03% 802
2016
Q2
$1.77M Sell
44,394
-1,770
-4% -$63.7K 0.02% 805
2016
Q1
$1.55M Sell
46,164
-1,476
-3% -$46K 0.02% 885
2015
Q4
$1.61M Buy
47,640
+618
+1% +$19.3K 0.02% 875
2015
Q3
$1.4M Sell
47,022
-5,758
-11% -$180K 0.02% 945
2015
Q2
$1.45M Sell
52,780
-2,836
-5% -$75.6K 0.02% 983
2015
Q1
$1.4M Buy
55,616
+13
+0% +$307 0.02% 1038
2014
Q4
$1.23M Sell
55,603
-84
-0.2% -$1.7K 0.01% 1094
2014
Q3
$1.13M Sell
55,687
-3,114
-5% -$62K 0.01% 1089
2014
Q2
$1.13M Buy
58,801
+374
+0.6% +$6.97K 0.01% 1161
2014
Q1
$1.1M Sell
58,427
-1,962
-3% -$37.9K 0.01% 1166
2013
Q4
$1.18M Buy
60,389
+7,261
+14% +$133K 0.01% 1149
2013
Q3
$874K Sell
53,128
-2,326
-4% -$37.3K 0.01% 1231
2013
Q2
$830K Buy
+55,454
New +$813K 0.01% 1239

Other funds holding IART

Texas Permanent School Fund's IART Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 59,524 shares — an estimated $2.11M sold.

Texas Permanent School Fund first reported a position in IART in Q2 2013 and held it in 44 quarters. The position peaked at $3.74M in Q1 2023. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 59,524 Integra LifeSciences shares in Q2 2024, an estimated $2.11M.
  • Texas Permanent School Fund first reported a position in Integra LifeSciences in Q2 2013 and held it in 44 quarters.
  • Texas Permanent School Fund's Integra LifeSciences position peaked at $3.74M in Q1 2023.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.